SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-18-005920
Filing Date
2018-08-09
Accepted
2018-08-09 12:46:24
Documents
38
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_080818p.htm 10-Q 294285
2 EXHIBIT 31.1 exh_311.htm EX-31.1 8562
3 EXHIBIT 31.2 exh_312.htm EX-31.2 7710
4 EXHIBIT 32.1 exh_321.htm EX-32.1 4086
  Complete submission text file 0001171843-18-005920.txt   1828448

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE xbit-20180630.xml EX-101.INS 292311
6 XBRL SCHEMA FILE xbit-20180630.xsd EX-101.SCH 20652
7 XBRL CALCULATION FILE xbit-20180630_cal.xml EX-101.CAL 19413
8 XBRL DEFINITION FILE xbit-20180630_def.xml EX-101.DEF 152964
9 XBRL LABEL FILE xbit-20180630_lab.xml EX-101.LAB 146187
10 XBRL PRESENTATION FILE xbit-20180630_pre.xml EX-101.PRE 165927
Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37347 | Film No.: 181004252
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences